EUVIMEDEUVIMED entdecken
Crossref

A sustainable RP‐HPLC method for concurrent estimation of capecitabine and celecoxib in liposomal formulation: Greenness and whiteness appraisal

Rushikesh Sanjay Shewale, Shyam Sudhakar Gomte, Aakanchha Jain

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Rushikesh Sanjay Shewale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Go…. Hauptthemen laut MEDLINE: Celecoxib, Liposomes, Capecitabine, Chromatography, Reverse-Phase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomes have been reported for combination therapy due to their ability to carry both hydrophilic and lipophilic drugs together. The current investigation aims to develop a novel, eco‐friendly, and sustainable reverse‐phase high‐performance liquid chromatography (RP‐HPLC) method for the simultaneous quantification of capecitabine and celecoxib co‐encapsulated in liposomes. The method reported herein uses a C 18 column (4.6 × 250 mm 2 , 5 μm) and a mobile phase consisting of water, and acetonitrile/methanol in a ratio of 60:40, containing 0.1% formic acid in both the phases. The flow rate is maintained at 1 mL/min, with an injection volume of 10 μL in the gradient mode. Detection is set at λ max = 240 nm for capecitabine and 252 nm for celecoxib. The developed liposomes are mono‐disperse with a surface potential of −6.93 mV. The average size of the liposomes is 142 nm. The percentage entrapment efficiency for capecitabine is 52.39 ± 0.94%, and for celecoxib, it is 77.13 ± 0.74%. The Analytical Greenness Metric of 0.61 and Analytical Eco‐Scale Score of 75 signify the greenness of the developed method. Also, the Red‐Green‐Blue model shows excellent whiteness, with a score of 83.2. Thus, the developed method offers a reliable, accurate, precise, buffer‐free, and environment‐friendly RP‐HPLC approach for the simultaneous analysis of capecitabine and celecoxib co‐encapsulated in liposomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CelecoxibLiposomesCapecitabineChromatography, Reverse-PhaseChromatography, High Pressure LiquidParticle SizeGreen Chemistry TechnologyDrug Compounding

Stichwörter der Autor:innen

RP‐HPLCcapecitabinecelecoxibgreennessliposome

Substanzen

CelecoxibLiposomesCapecitabine

Autor:innen und Institutionen

  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Department of Pharmaceuticals, Ministry of Chemical…

Förderung

  • None

Zitieren

APA

Shewale, R. S., Gomte, S. S., & Jain, A. (2024). A sustainable RP‐HPLC method for concurrent estimation of capecitabine and celecoxib in liposomal formulation: Greenness and whiteness appraisal. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400632

Vancouver

Shewale RS, Gomte SS, Jain A. A sustainable RP‐HPLC method for concurrent estimation of capecitabine and celecoxib in liposomal formulation: Greenness and whiteness appraisal. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400632

BibTeX
@article{Shewale2024,
  author = {Shewale, Rushikesh Sanjay and Gomte, Shyam Sudhakar and Jain, Aakanchha},
  title = {A sustainable RP‐HPLC method for concurrent estimation of capecitabine and celecoxib in liposomal formulation: Greenness and whiteness appraisal},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400632}
}
Kostenlos starten →